Septodont Nederland

About Septodont Nederland

Since Septodont was founded in 1932, the company has always been at the forefront of the dental pharmaceutical world. Development, production, and distribution of a wide range of quality products for dental professionals worldwide are part of Septodont's core business. Dentists around the world know they can rely on the consistent quality of our products. This trust has made Septodont the world leader in local anesthetics. Annually, 500 million dental injections are administered with Septodont anesthetics. In addition to products that help with pain management, Septodont has introduced an innovative range of products for restorative dentistry. Following the introduction of Biodentine™, a groundbreaking and patented dentine substitute for which over 100 publications have appeared worldwide, we recently launched Bioroot RCS®. A bioactive material for sealing root canals, with demonstrable bioactive properties. Septodont is involved in the development of a range of bioactive materials with interesting applications in restorative, endodontic, and regenerative dentistry. All this is based on the patented “Active Biosilicate Technology”. The group has 1,700 employees and remains a 100% family business led by CEO, Olivier Schiller. Septodont Benelux is located in Ganshoren (Brussels).